Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · IEX Real-Time Price · USD
3.010
-0.230 (-7.10%)
Jul 17, 2024, 4:00 PM EDT - Market closed

Kodiak Sciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2016
Selling, General & Admin
69.0571.0273.7949.7128.6211.68
Upgrade
Research & Development
179.71206.3267.59217.34107.3937.51
Upgrade
Operating Expenses
248.76277.32341.38267.05136.0149.19
Upgrade
Operating Income
-248.76-277.32-341.38-267.05-136.01-49.19
Upgrade
Interest Expense / Income
0.010.010.020.050.030.01
Upgrade
Other Expense / Income
-16.02-16.84-7.57-0.11-2.94-1.83
Upgrade
Pretax Income
-232.75-260.49-333.82-266.99-133.1-47.37
Upgrade
Net Income
-232.75-260.49-333.82-266.99-133.1-47.37
Upgrade
Shares Outstanding (Basic)
535252524638
Upgrade
Shares Outstanding (Diluted)
535252524638
Upgrade
Shares Change
0.33%0.32%0.89%13.22%20.84%152.75%
Upgrade
EPS (Basic)
-4.43-4.97-6.39-5.16-2.91-1.25
Upgrade
EPS (Diluted)
-4.43-4.97-6.39-5.16-2.91-1.25
Upgrade
Free Cash Flow
-175.76-195.61-253.82-245.57-90.43-39.58
Upgrade
Free Cash Flow Per Share
-3.35-3.73-4.86-4.74-1.98-1.05
Upgrade
EBITDA
-205.8-234.53-322.8-258.23-128.86-46.45
Upgrade
Depreciation & Amortization
26.9425.95118.714.210.91
Upgrade
EBIT
-232.74-260.48-333.81-266.94-133.07-47.36
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).